Stefano Serra

Enteroblastic and Hepatoid Colorectal Carcinomas are Aggressive Cancers With a Distinctive Immunophenotype, While Clear Cell Carcinoma Appears to Represent Clear Cell Change in Conventional Colorectal Cancer.

Khan F, Polydorides AD, Paulsen JD, Chen W, Vazzano J, Huber A, Papke D, Sharifai N, Stashek K, Ruz-Caracuel I, Allende D, McHugh K, Shia J, Longacre TA, Dhall D, Makhoul E, Lee MJ, Collins K, Ulbright TM, Zhang ML, Westerhoff M, Gao ZH, Matsukuma K, Choi WT, Kakar S, Chetty R, Nowak K, Serra S, Zhang X, Chen W, Gonzalez RS

Neuroendocrine differentiation and serotonin expression in oesophageal adenocarcinomas after neoadjuvant therapy: correlation with clinicopathological features and outcome.

Dodington DW, Serra S, Bracey T, Chetty R, Nowak KM

Are deeper sections and immunohistochemistry useful in detecting micrometastases and isolated tumour cells in colorectal cancer?

Dodington DW, Guidolin K, Quereshy F, Chetty R, Serra S, Nowak KM

Mueller matrix polarization parameters correlate with local recurrence in patients with stage III colorectal cancer.

Tumanova K, Serra S, Majumdar A, Lad J, Quereshy F, Khorasani M, Vitkin A

Machine learning based local recurrence prediction in colorectal cancer using polarized light imaging

Distinguishing Gastric/Esophageal Adenocarcinoma from Pancreatic Adenocarcinoma Using Methylation-Based Droplet Digital PCR.

Xia D, Nowak K, Leon AJ, Winegarden N, Wong A, Boruvka N, Diamandis P, Chetty R, Pugh T, Zhang T, Aldape K, Stockley T, Serra S

Polarimetric biomarkers of peri-tumoral stroma can correlate with 5-year survival in patients with left-sided colorectal cancer.

Lad J, Serra S, Quereshy F, Khorasani M, Vitkin A

Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers.

Pham NA, Radulovich N, Ibrahimov E, Martins-Filho SN, Li Q, Pintilie M, Weiss J, Raghavan V, Cabanero M, Denroche RE, Wilson JM, Metran-Nascente C, Borgida A, Hutchinson S, Dodd A, Begora M, Chadwick D, Serra S, Knox JJ, Gallinger S, Hedley DW, Muthuswamy L, Tsao MS

Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer.

Alshammari K, Aung KL, Zhang T, Razak ARA, Serra S, Stockley T, Wang L, Nguyen J, Spreafico A, Hansen AR, Zwir D, Siu LL, Bedard PL

SMARCA family of genes.

Chetty R, Serra S